Navigation Links
Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference
Date:3/19/2012

SAN DIEGO and PHILADELPHIA, March 19, 2012 /PRNewswire/ -- Toby Odenheim, director of IT services at Synteract, Inc., a full-service contract research organization (CRO), is slated to present on Selecting the Optimum EDC Platform to Support your Clinical Program at the Outsourcing in Clinical Trials, East Coast conference, to be held in Philadelphia, March 27-28, 2012. Odenheim will speak at 11 a.m. EDT, Wed., March 28, discussing a variety of drivers to consider when selecting the right EDC (electronic data capture) platform for clinical project needs.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

The conference is geared towards solution-seeking professionals who want focused research-generated content and innovative strategies to manage the increased complexities in today's drug development environment. Odenheim will discuss working with clients to identify the key drivers for consideration when evaluating electronic data capture platforms to match program needs, such as:

  • Developing a checklist and risk-benefit evaluation to assist in decision-making
  • Assessing different platforms during a clinical program to enhance productivity, cost efficiency and expedite decision points
  • Scrutinizing EDC systems for biotech and pharma development needs

Odenheim has been with Synteract for seven years. He has a master's in business administration and a bachelor's degree in biology, as well as a professional Oracle Database Administration certificate from the University of California San Diego.

According to Stewart Bieler, chief operating officer, Odenheim was chosen to present on behalf of Synteract due to his clear understanding of how critical the application of appropriate technologies is in driving efficiencies and productivity in drug development.

"This is a complex industry that is changing all the time, and clients want to be assured their project will be in the right hands, with a company that has experience helping clients choose the right tools and technology for their drug development needs. Toby has assessed and helped to deliver solutions to clients that best fit their unique program requirements, driving projects and results forward at the same time."

Synteract will exhibit in booth #35; Synteract CEO, Wendel Barr, will also be on hand at the event. Synteract will answer questions about the multiple software and technology platforms it supports within the framework of its full-service CRO capabilities and will discuss how its more than 17 years of experience across a wide range of therapeutic areas can fit specific project needs. To set up an appointment in advance, contact Michele Sacher, associate business development director, at 484.467.5937 or at msacher@synteract.com 

About Synteract (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
760-230-2424

 


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
2. InspireMD Appoints Dr. James Barry to Its Board of Directors
3. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
4. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
5. Berkeley Lab Director Paul Alivisatos wins Wolf Prize in Chemistry
6. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
7. Robert Farrell Joins Bionovos Board of Directors
8. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
9. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. BioStorage Technologies Appoints New Member to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... CA (PRWEB) , ... June 28, 2017 , ... ... in the international market with three research projects accepted for presentation at the ... (ESHRE) . Nearly 10,000 participants – including some of the world’s top thought ...
(Date:6/28/2017)... and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics computational fluid ... enable automated product design exploration and optimization. STAR-CCM+ version 12.04 introduces Design ...
(Date:6/28/2017)... ... June 28, 2017 , ... Studies indicate that replacing ... an effective treatment for Parkinson’s disease. But what has not been determined is the ... to gain the best results. , A new study coming out of Singapore, recently ...
(Date:6/27/2017)... ... June 27, 2017 , ... Brain State Technologies, a leading ... on June 15th to fund production of the new B2v2 wearable brainwave balancing ... goal by more than 150% in a little over a week. , Utilizing ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... 2017 No two people are believed ... New York University Tandon School of Engineering and ... that partial similarities between prints are common enough ... phones and other electronic devices can be more ... lies in the fact that fingerprint-based authentication systems ...
Breaking Biology News(10 mins):